Key Highlights
- Haemonetics (NYSE:HAE) rose 16.05 percent to USD 118.03 on 1.301 million shares, 1.9 times its three-month average, after CSL expanded its plasma deployment, with a Market Value of USD 5.37 billion, and its 52-week change is 102.81 percent.
- Wolfspeed (NYSE:WOLF) fell 3.67 percent to USD 30.22 on 15.374 million shares, 4.3 times its three-month average, after giving up a premarket jump on a USD 1.5 billion Pentagon loan commitment, with a market value of USD 1.599 billion.
- Palantir Technologies (NASDAQ:PLTR) rose 2.50 percent to USD 198.96 on 26.001 million shares, 0.8 times its three-month average, after Goldman Sachs upgraded it to Buy with a USD 230 target, with a market value of USD 478.088 billion.
- Broadcom (NASDAQ:AVGO) eased about 1.4 percent in premarket trading on October 8 as chip stocks slipped, and a market report cited Goldman Sachs strategist comments that the company is exploring more than USD 50 billion of financing.
Haemonetics (NYSE:HAE): CSL Rollout Update
Haemonetics (NYSE:HAE) rose 16.05 percent to USD 118.03 on Volume of 1.301 million shares versus a three-month average of 678,940, with a market Capitalization of USD 5.37 billion, a P/E of 57.02 and a 52-week change of 102.81 percent. CSL said it expects to deploy Haemonetics' NexSys PCS plasma collection devices at all of its US centers by the end of calendar 2027, building on an August 18 non-exclusive Supply agreement. Haemonetics did not update fiscal 2027 guidance and will discuss the impact on its November earnings call. The agreement is non-exclusive, and rollout scope and timing can change. By market value it ranks 2 of 3 in this group and 1 of 3 on the day's change, from best to worst. Its volume was 1.9 times its three-month average, against a range of 0.8 to 4.3 times across this group. It accounts for 1.1 percent of the group's combined market value, and its 52-week change of 102.81 percent compares with a group average of 32.01 percent. What to watch next: the November Earnings Call and CSL rollout scope. The backdrop matters: on October 7 the Russell 2000 fell 1.31 percent to 2,793.20, the 10-year Treasury Yield touched about 5.35 percent, its highest since 2002, and oil rose nearly 4 percent on October 8.
Wolfspeed (NYSE:WOLF): Pentagon Loan Gain Fades
Wolfspeed (NYSE:WOLF) fell 3.67 percent to USD 30.22 on volume of 15.374 million shares versus a three-month average of 3.602 million, with a market capitalization of USD 1.599 billion, no trailing P/E and a 52-week change of negative 11.43 percent. Wolfspeed rose 14 to 17 percent in premarket trading after the Department of Defense announced a USD 1.5 billion conditional Loan Commitment to the silicon carbide maker, but the screener shows the stock down 3.67 percent, so the early gain was sold. A conditional loan is not cash in hand, and losses and Leverage remain the core risks. By market value it ranks 3 of 3 in this group and 3 of 3 on the day's change, from best to worst. Its volume was 4.3 times its three-month average, against a range of 0.8 to 4.3 times across this group. It accounts for 0.3 percent of the group's combined market value, and its 52-week change of negative 11.43 percent compares with a group average of 32.01 percent. What to watch next: loan conditions and cash burn. Long-term borrowing costs also matter: the 30-year Treasury yield reached about 5.7 percent, a 24-year high, on October 7.
Palantir Technologies (NASDAQ:PLTR): Goldman Upgrade and USD 230 Target
Palantir Technologies (NASDAQ:PLTR) rose 2.50 percent to USD 198.96 on volume of 26.001 million shares versus a three-month average of 33.325 million, with a market capitalization of USD 478.088 billion, a P/E of 171.51 and a 52-week change of 4.66 percent. Goldman Sachs analyst Gabriela Borges upgraded Palantir from Neutral to Buy on October 8, saying the addressable market may be setting up for another step change as sovereign AI and bespoke applications spread. Yorkville Ives initiated coverage a day earlier with an Outperform rating and a USD 250 target, and the stock closed at USD 194.12 on October 7, within about USD 13 of its record near USD 207. Second-quarter Revenue was USD 1.94 billion and Net Income USD 1.06 billion, per published data. A P/E of 171.51 leaves little room for slower growth, and a rate-driven multiple squeeze would hit the stock first. By market value it ranks 1 of 3 in this group and 2 of 3 on the day's change, from best to worst. Its volume was 0.8 times its three-month average, against a range of 0.8 to 4.3 times across this group. It accounts for 98.6 percent of the group's combined market value, and its 52-week change of 4.66 percent compares with a group average of 32.01 percent. What to watch next: the USD 250 and USD 230 targets, government contracts and the next earnings report. index context: the S&P 500 closed at 7,801.77 and the Nasdaq Composite at 27,538.69 on October 7, each down 0.22 percent from records set a day earlier.
Broadcom (NASDAQ:AVGO): USD 50 Billion Financing Talk
Broadcom eased about 1.4 percent in premarket trading on October 8 as chip stocks slipped. A market report cited Goldman Sachs strategist comments that Broadcom is exploring more than USD 50 billion of financing. Heavy financing needs add to the crowding-out concern raised by Goldman. What to watch next: financing terms and chip sentiment. The Dow Jones Industrial Average fell 0.66 percent to 51,179.87 on October 7, so breadth was weak outside the largest technology names.
Where Things Stand
Premarket gains did not all hold: Haemonetics and Palantir kept gains, Wolfspeed reversed and Broadcom slipped. Haemonetics (NYSE:HAE) rose 16.05 percent with a market value of USD 5.37 billion. Wolfspeed (NYSE:WOLF) fell 3.67 percent with a market value of USD 1.599 billion. Palantir Technologies (NASDAQ:PLTR) rose 2.50 percent with a market value of USD 478.088 billion. Broadcom (NASDAQ:AVGO) as chip names stayed under pressure. Market conditions framed the day: the Russell 2000 fell 1.31 percent on October 7 and the 10-year Treasury yield touched about 5.35 percent. A one-day move gives no information about direction, and each name carries its own risks.






Please wait processing your request...